927 RISK FOR HEPATOCELLULAR CARCINOMA IN AUTOIMMUNE HEPATITIS – IS THERE AN INDICATION FOR SURVEILLANCE? von Danielsson Borssén, Å, Lindgren, S, Bergquist, A, Almer, S, Sangfelt, P, Werner, M

Volltext

Improved Survival in At-Risk Patients Undergoing Surveillance for Hepatocellular Carcinoma – A Nationwide Swedish Register-Based Study von Thörn, Richard, Hemmingsson, Oskar, Danielsson Borssén, Åsa, Werner, Mårten, Karling, Pontus, Wixner, Jonas

Volltext

Risk for hepatocellular carcinoma in autoimmune hepatitis: is there an indication for surveillance? von Danielsson Borssen, Åsa, Lindgren, S, Bergquist, A, Almer, S, Sangfelt, P, Werner, Mårten

Volltext

Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD von Hegmar, Hannes, Wiggers, Thomas, Nasr, Patrik, Vessby, Johan, Kechagias, Stergios, Nyhlin, Nils, Marschall, Hanns‐Ulrich, Borssén, Åsa Danielsson, Strandberg, Rickard, Karsdal, Morten, Leeming, Diana Julie, Ekstedt, Mattias, Hagström, Hannes

Volltext

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study von Borssén, Åsa D., Palmqvist, Richard, Kechagias, Stergios, Marschall, Hanns-Ulrich, Bergquist, Annika, Rorsman, Fredrik, Weiland, Ola, Verbaan, Hans, Nyhlin, Nils, Nilsson, Emma, Werner, Mårten

Volltext